Gizli Tehlike; Agmatin
Öz
References
- Uzbay T. The pharmacological importance of agmatine in the brain. Neurosci Biobehav Rev, 2012; 36: 502-19.
- Uzbay T. A new target for diagnosis and treatment of CNS disorders: agmatinergic system. Curr Med Chem, 2012; 19: 5116-21.
- Uzbay IT, Kayir H, Goktalay G, Yildirim M. Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats. J Psychopharmacol, 2010; 24: 923-29.
- Uzbay T, Goktalay G, Kayir H, Eker SS, Sarandol A, Oral S, Buyukuysal L, Ulusoy G, Kirli S. Increased plasma agmatine levels in patients with schizophrenia. J Psychiatr Res, 2013; 47: 1054-60.
- Yeşilyurt Ö, Uzbay İT. Agmatine potentiates the analgesic effect of morphine by an alpha-2-adrenoceptor-mediated mechanism in mice. Neuropsychopharmacology, 20012; 25: 98-103.
- Aricioğlu-Kartal F, Uzbay IT. Inhibitory effect of agmatine on naloxone- precipitated abstinence syndrome in morphine dependent rats. Life Sci, 1997; 61: 1775-81.
- Richardson-Andrews RC. A central role for the polyamines in the aetiology of schizophrenia. Med Hypotheses 1983; 11: 157-66.
- Das I, de Belleroche J, Essali MA, Richardson-Andrews RC, Hirsch SR. Blood polyamines in schizophrenia. Schizophr Res 1989; 2: 146.
Details
Primary Language
Turkish
Subjects
-
Journal Section
-
Authors
Korkut Ulucan
Tayfun Uzbay
Publication Date
September 1, 2016
Submission Date
-
Acceptance Date
-
Published in Issue
Year 2016 Number: 3